IL216148A0 - Stable forms of n-(2,6-dimethyl-4-morpholin-4-yl-phenyl)-3,3-dimethyl-butyramide - Google Patents
Stable forms of n-(2,6-dimethyl-4-morpholin-4-yl-phenyl)-3,3-dimethyl-butyramideInfo
- Publication number
- IL216148A0 IL216148A0 IL216148A IL21614811A IL216148A0 IL 216148 A0 IL216148 A0 IL 216148A0 IL 216148 A IL216148 A IL 216148A IL 21614811 A IL21614811 A IL 21614811A IL 216148 A0 IL216148 A0 IL 216148A0
- Authority
- IL
- Israel
- Prior art keywords
- dimethyl
- butyramide
- morpholin
- phenyl
- stable forms
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
- C07D295/12—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms
- C07D295/135—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms with the ring nitrogen atoms and the substituent nitrogen atoms separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
- C07D295/06—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by halogen atoms or nitro radicals
- C07D295/073—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by halogen atoms or nitro radicals with the ring nitrogen atoms and the substituents separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
- A61K31/5375—1,4-Oxazines, e.g. morpholine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Neurology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Hospice & Palliative Care (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
- Cosmetics (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DKPA200900597 | 2009-05-11 | ||
PCT/DK2010/050101 WO2010130260A2 (en) | 2009-05-11 | 2010-05-11 | Stable forms of n-(2,6-dimethyl-4-morpholin-4-yl-phenyl)-3,3-dimethyl-butyramide |
Publications (1)
Publication Number | Publication Date |
---|---|
IL216148A0 true IL216148A0 (en) | 2012-01-31 |
Family
ID=42237259
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL216148A IL216148A0 (en) | 2009-05-11 | 2011-11-03 | Stable forms of n-(2,6-dimethyl-4-morpholin-4-yl-phenyl)-3,3-dimethyl-butyramide |
Country Status (23)
Country | Link |
---|---|
EP (1) | EP2430008A2 (es) |
JP (1) | JP2012526152A (es) |
KR (1) | KR20120022934A (es) |
CN (1) | CN102459208A (es) |
AR (1) | AR076556A1 (es) |
AU (1) | AU2010246724B2 (es) |
BR (1) | BRPI1013930A2 (es) |
CA (1) | CA2761383A1 (es) |
CL (1) | CL2011002814A1 (es) |
CO (1) | CO6460741A2 (es) |
CR (1) | CR20110590A (es) |
DO (1) | DOP2011000351A (es) |
EA (1) | EA201171381A1 (es) |
GE (1) | GEP20146006B (es) |
IL (1) | IL216148A0 (es) |
MA (1) | MA33351B1 (es) |
MX (1) | MX2011011885A (es) |
NZ (1) | NZ596738A (es) |
SG (1) | SG175968A1 (es) |
TN (1) | TN2011000557A1 (es) |
TW (1) | TW201041857A (es) |
WO (1) | WO2010130260A2 (es) |
ZA (1) | ZA201108112B (es) |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
TWI357901B (en) * | 2004-03-12 | 2012-02-11 | Lundbeck & Co As H | Substituted morpholine and thiomorpholine derivati |
KR20090079191A (ko) * | 2006-08-23 | 2009-07-21 | 밸리언트 파마슈티컬즈 인터내셔널 | 칼륨 채널 조절제로서 4-(n-아자사이클로알킬) 아닐리드의 유도체 |
BRPI0814180A2 (pt) * | 2007-08-01 | 2015-01-27 | Lundbeck & Co As H | Método para reduzir os sintomas de, ou para tratar, um ou mais distúrbios nos quais o sistema dopaminérgico está desregulado |
-
2010
- 2010-05-06 TW TW099114459A patent/TW201041857A/zh unknown
- 2010-05-10 AR ARP100101588A patent/AR076556A1/es unknown
- 2010-05-11 KR KR1020117026958A patent/KR20120022934A/ko not_active Application Discontinuation
- 2010-05-11 CN CN2010800321765A patent/CN102459208A/zh active Pending
- 2010-05-11 BR BRPI1013930A patent/BRPI1013930A2/pt not_active IP Right Cessation
- 2010-05-11 JP JP2012510116A patent/JP2012526152A/ja active Pending
- 2010-05-11 EA EA201171381A patent/EA201171381A1/ru unknown
- 2010-05-11 MX MX2011011885A patent/MX2011011885A/es not_active Application Discontinuation
- 2010-05-11 EP EP10719726A patent/EP2430008A2/en not_active Withdrawn
- 2010-05-11 GE GEAP201012498A patent/GEP20146006B/en unknown
- 2010-05-11 CA CA2761383A patent/CA2761383A1/en not_active Abandoned
- 2010-05-11 SG SG2011082492A patent/SG175968A1/en unknown
- 2010-05-11 NZ NZ596738A patent/NZ596738A/xx not_active IP Right Cessation
- 2010-05-11 WO PCT/DK2010/050101 patent/WO2010130260A2/en active Application Filing
- 2010-05-11 AU AU2010246724A patent/AU2010246724B2/en not_active Ceased
- 2010-05-11 MA MA34435A patent/MA33351B1/fr unknown
-
2011
- 2011-11-03 IL IL216148A patent/IL216148A0/en unknown
- 2011-11-04 TN TNP2011000557A patent/TN2011000557A1/en unknown
- 2011-11-04 ZA ZA2011/08112A patent/ZA201108112B/en unknown
- 2011-11-10 CL CL2011002814A patent/CL2011002814A1/es unknown
- 2011-11-11 DO DO2011000351A patent/DOP2011000351A/es unknown
- 2011-11-11 CR CR20110590A patent/CR20110590A/es unknown
- 2011-11-11 CO CO11153611A patent/CO6460741A2/es not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
MA33351B1 (fr) | 2012-06-01 |
WO2010130260A3 (en) | 2011-06-16 |
ZA201108112B (en) | 2013-01-30 |
CO6460741A2 (es) | 2012-06-15 |
SG175968A1 (en) | 2011-12-29 |
CA2761383A1 (en) | 2010-11-18 |
WO2010130260A2 (en) | 2010-11-18 |
CN102459208A (zh) | 2012-05-16 |
AR076556A1 (es) | 2011-06-22 |
EP2430008A2 (en) | 2012-03-21 |
EA201171381A1 (ru) | 2012-05-30 |
GEP20146006B (en) | 2014-01-10 |
DOP2011000351A (es) | 2012-01-31 |
KR20120022934A (ko) | 2012-03-12 |
CL2011002814A1 (es) | 2012-04-13 |
JP2012526152A (ja) | 2012-10-25 |
MX2011011885A (es) | 2011-12-06 |
TW201041857A (en) | 2010-12-01 |
AU2010246724B2 (en) | 2013-03-21 |
BRPI1013930A2 (pt) | 2019-09-24 |
WO2010130260A9 (en) | 2012-10-18 |
AU2010246724A1 (en) | 2011-12-08 |
TN2011000557A1 (en) | 2013-05-24 |
NZ596738A (en) | 2013-04-26 |
CR20110590A (es) | 2012-02-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1199031A1 (en) | Substituted 2-acetamido-5-aryl-1,2,4-triazolones and use thereof 2--5--1,2,4- | |
HK1194071A1 (en) | Certain triazolopyrazines, compositions thereof and methods of use therefor | |
GB0914644D0 (en) | Novel agents and uses thereof | |
HK1204227A1 (en) | Benzamide derivatives | |
SI2398785T1 (sl) | Äśiĺ äśenje 1-(2-(2,4-dimetilfenilsulfanil)fenil)-piperazina | |
EP2427995A4 (en) | PROACTIVE AUTHENTICATION | |
GB0917044D0 (en) | Agents, uses and methods | |
GB0917054D0 (en) | Agents, uses and methods | |
EP2518338A4 (en) | TERMINAL | |
ZA201203137B (en) | Substituted benzamide derivatives | |
EP2451302A4 (en) | HAIR ACCESSORIES | |
HK1171451A1 (en) | Sulfonic amide and sulfoximine-substituted diaryl-dihydropyrimidinones and usage thereof -- | |
EP2470499A4 (en) | NEW COLCHICINE DERIVATIVE AND METHOD AND USES THEREOF | |
EP2598170A4 (en) | MEDICAMENT-LIGAND CONJUGATES, THEIR SYNTHESIS AND CORRESPONDING INTERMEDIATES | |
EP2351732A4 (en) | NEW RAMALINE CONNECTION AND ITS USE | |
EP2416020A4 (en) | TERMINAL | |
EP2311472A4 (en) | AGENT FOR THE IMPROVEMENT OF COGNITIVE DISORDERS | |
EP2281810A4 (en) | AMID COMPOUNDS AND PROCESS FOR THEIR MANUFACTURE AND APPLICATIONS THEREOF | |
IL215153A0 (en) | Amide derivative compounds, compositions comprising the same and uses there of | |
IL216462A0 (en) | Nitrile derivatives, compositions comprising the same and uses thereof | |
IL217928A0 (en) | Amide derivatives, compositions comprising the same and uses thereof | |
EP2444330A4 (en) | TERMINAL | |
EP2493904A4 (en) | N-SUBSTITUTED ACRYLAMIDES, MANUFACTURING METHOD AND USES | |
IL230655A0 (en) | Derivatives n-hetero-converted in the amide ring, preparations containing them and their uses | |
ZA201108112B (en) | Stable forms of n-(2,6-dimethyl-4-morpholin-4-yl-phenyl)-3,3-dimethyl-butyramide |